Abstract: The present invention is directed to a monoclonal antibody that binds specifically to a Staphylococcus aureus glucosaminidase and inhibits in vivo growth of S. aureus. Also disclosed are monoclonal antibody binding portions, recombinant or hybridoma cell lines, pharmaceutical compositions containing the monoclonal antibody or binding portions thereof, and methods of treating S. aureus infection and osteomyelitis, and methods for introducing an orthopedic implant into a patient using the monoclonal antibody, binding portion, or pharmaceutical composition of the present invention.

Abstract: The present invention is directed to a monoclonal antibody that binds specifically to a Staphylococcus aureus glucosaminidase and inhibits in vivo growth of S. aureus. Also disclosed are monoclonal antibody binding portions, recombinant or hybridoma cell lines, pharmaceutical compositions containing the monoclonal antibody or binding portions thereof, and methods of treating S. aureus infection and osteomyelitis, and methods for introducing an orthopedic implant into a patient using the monoclonal antibody, binding portion, or pharmaceutical composition of the present invention.

Abstract: A liquid diffuser includes a base, a liquid reservoir, a spout for resting on the reservoir and having an upper opening, a fan, a polymeric gasket encircling the liquid reservoir, and a cover. The gasket includes a flange extending over a portion of an upper surface of the base that extends laterally beyond the liquid reservoir. The cover is sized and configured to be positioned over and around the liquid reservoir and the spout, and to rest upon the flange of the gasket. Methods of assembling such a liquid diffuser include resting the spout upon the liquid reservoir, and resting the spout upon the flange of the gasket over the base. Method of using such a liquid diffuser include powering a transducer for generating atomized droplets of the liquid, and supplying power to the fan to carry the atomized droplets of the liquid out from the diffuser with forced airflow.

Abstract: A composite article is provided for use as a heat spreader, a cooling element or as part of the heating system for a wide variety of items. The composite article can include at least one sheet of compressed particles of exfoliated graphite or graphitized polymer. A protective coating may be aligned or adhered with a surface of the sheet. The article may also include at least on of a fiber reinforced polymer, a fiber weave or fiber mat or combinations thereof, aligned with at least one of the first surface of the sheet or a second surface of the sheet. The composite article can include a plurality of strips of compressed particles of exfoliated graphite, of graphitized polymer or combinations thereof, which are woven together and/or it can include cut outs, slits or other perforations to provide flexibility, stretchability, and breathability.

Abstract: A liquid diffuser includes a base, a liquid reservoir, a spout for resting on the reservoir and having an upper opening, a fan, a polymeric gasket encircling the liquid reservoir, and a cover. The gasket includes a flange extending over a portion of an upper surface of the base that extends laterally beyond the liquid reservoir. The cover is sized and configured to be positioned over and around the liquid reservoir and the spout, and to rest upon the flange of the gasket. Methods of assembling such a liquid diffuser include resting the spout upon the liquid reservoir, and resting the spout upon the flange of the gasket over the base. Method of using such a liquid diffuser include powering a transducer for generating atomized droplets of the liquid, and supplying power to the fan to carry the atomized droplets of the liquid out from the diffuser with forced airflow.

Abstract: The present invention is directed to a monoclonal antibody that binds specifically to a Staphylococcus aureus glucosaminidase and inhibits in vivo growth of S. aureus. Also disclosed are monoclonal antibody binding portions, recombinant or hybridoma cell lines, pharmaceutical compositions containing the monoclonal antibody or binding portions thereof, and methods of treating S. aureus infection and osteomyelitis, and methods for introducing an orthopedic implant into a patient using the monoclonal antibody, binding portion, or pharmaceutical composition of the present invention.

Abstract: The present invention is directed to a monoclonal antibody that binds specifically to a Staphylococcus aureus glucosaminidase and inhibits in vivo growth of S. aureus. Also disclosed are monoclonal antibody binding portions, recombinant or hybridoma cell lines, pharmaceutical compositions containing the monoclonal antibody or binding portions thereof, and methods of treating S. aureus infection and osteomyelitis, and methods for introducing an orthopedic implant into a patient using the monoclonal antibody, binding portion, or pharmaceutical composition of the present invention.

Abstract: The present invention is directed to a monoclonal antibody that binds specifically to a Staphylococcus aureus glucosaminidase and inhibits in vivo growth of S. aureus. Also disclosed are monoclonal antibody binding portions, recombinant or hybridoma cell lines, pharmaceutical compositions containing the monoclonal antibody or binding portions thereof, and methods of treating S. aureus infection and osteomyelitis, and methods for introducing an orthopedic implant into a patient using the monoclonal antibody, binding portion, or pharmaceutical composition of the present invention.

Abstract: The present invention is directed to a monoclonal antibody that binds specifically to a Staphylococcus aureus glucosaminidase and inhibits in vivo growth of S. aureus. Also disclosed are monoclonal antibody binding portions, recombinant or hybridoma cell lines, pharmaceutical compositions containing the monoclonal antibody or binding portions thereof, and methods of treating 5*. aureus infection and osteomyelitis, and methods for introducing an orthopedic implant into a patient using the monoclonal antibody, binding portion, or pharmaceutical composition of the present invention.

Abstract: A method for appending location data to behavior profiles, includes tracking a number of impressions for a user when the user is on-line, tracking a number of opportunities for the user when the user is on-line, calculating a cost associated with the opportunities for the user, and determining an index for the user to quantify a qualitative value of the user. Therefore, exemplary embodiments use information gathered and associated about a user to provide different decision propositions to the providers of targeted information.

Abstract: A dual host system and method with back to back non-transparent bridges and a proxy packet generating mechanism. The proxy packet generating mechanism enables the hosts to send interrupt generating packets to each other.

Abstract: Hammer drills and similar devices have an ongoing dust and debris problem that is solved by a protector device covering the drill in a main body protector shielding a user from the materials. The protector device has an evacuation region on its underside with multi dimensional adapters for attaching hoses of varying sizes. Additionally, an insertable collapsible accordion cylinder assists in covering the debris falling from different size drills being used. A second embodiment has a circular saw dust protector attachment arranged as two half moons or ¼ moon and ¾ moon having a central cylinder at their respective tops that are to be held together with a mechanical latch.

Abstract: The present invention is directed to a monoclonal antibody that binds specifically to a Staphylococcus aureus glucosaminidase and inhibits in vivo growth of S. aureus. Also disclosed are monoclonal antibody binding portions, recombinant or hybridoma cell lines, pharmaceutical compositions containing the monoclonal antibody or binding portions thereof, and methods of treating S. aureus infection and osteomyelitis, and methods for introducing an orthopedic implant into a patient using the monoclonal antibody, binding portion, or pharmaceutical composition of the present invention.

Abstract: A platform for creating an advertising campaign may include a graphical user interface. The graphical user interface may be configured to permit a user to select a geographic area to define a target recipient group, identify a demographic parameter of the target recipient group, view an estimated statistic from the advertising campaign based on the target recipient group and demographic parameter, set campaign parameters, and associate an advertisement to the advertising campaign.

Abstract: System and method described herein may be used to relate a physical address of a user and an IP address of a user from on-line exchanges of the user. The method may include relating an IP address to an intermediate identifier, where the intermediate identifier is observed with the IP address during a single on-line exchange. The method may also include relating the physical address of the user to the intermediate identifier after an observed correlation between the physical address and the intermediate identifier. The method may also include relating the physical address of the user and the IP address of the user, where the physical address and the IP address are not observed together in a single on-line exchange.

Abstract: A rotary steerable drilling system that is operable to drill vertical wellbores and automatically maintain a vertical wellbore drilling path. The system includes a control module for operating solenoid valves that control an amount of fluid pressure applied to bias pad piston/cylinders. The control module is operable to determine when the system is deviating from vertical, in what direction the system is deviating, and where the bias pads are in relation to the direction of deviation. Based on these determinations, the control module actuates the requisite bias pads by controlling the amount of fluid pressure applied to the bias pad piston/cylinders to direct the system back to the vertical drilling path.

Abstract: The present invention is directed to a monoclonal antibody that binds specifically to a Staphylococcus aureus glucosaminidase and inhibits in vivo growth of S. aureus. Also disclosed are monoclonal antibody binding portions, recombinant or hybridoma cell lines, pharmaceutical compositions containing the monoclonal antibody or binding portions thereof, and methods of treating S. aureus infection and osteomyelitis, and methods for introducing an orthopedic implant into a patient using the monoclonal antibody, binding portion, or pharmaceutical composition of the present invention.

Abstract: A liquid diffuser includes a base, a liquid reservoir, a spout for resting on the reservoir and having an upper opening, a fan, a polymeric gasket encircling the liquid reservoir, and a cover. The gasket includes a flange extending over a portion of an upper surface of the base that extends laterally beyond the liquid reservoir. The cover is sized and configured to be positioned over and around the liquid reservoir and the spout, and to rest upon the flange of the gasket. Methods of assembling such a liquid diffuser include resting the spout upon the liquid reservoir, and resting the spout upon the flange of the gasket over the base. Method of using such a liquid diffuser include powering a transducer for generating atomized droplets of the liquid, and supplying power to the fan to carry the atomized droplets of the liquid out from the diffuser with forced airflow.

Abstract: Methods and systems disclosed provide for advertisement opportunities based on preselected user profiles and trigger events. The user profiles may comprise available impression times, index values and cost of acquisition. Advertisement content may be provided to devices associated with the preselected user profiles.